Psychiatr. praxi. 2022;23(1):13-16 | DOI: 10.36290/psy.2022.002

Mild behavioral impairment as a prodromal stage of neurodegenerative diseases

Mgr. Veronika Matušková1, doc. MUDr. Martin Vyhnálek, Ph.D.1
Kognitivní centrum, Neurologická klinika 2. LF UK a FN v Motole, Praha

Neuropsychiatric symptoms in older adults are part of the clinical manifestation of neurodegenerative diseases and may even be their first symptoms. We describe the concept of mild behavioral impairment (MBI), which refers to new-onset, persistent neuropsychiatric symptoms emerging after the age of 50 years that are assumed to have a neurodegenerative etiology. We introduce the newly adapted Czech version of the Mild behavioral impairment - checklist developed to measure neuropsychiatric symptoms in older adults and for the MBI detection.

Keywords: neuropsychiatric symptoms, mild behavioral impairment, neurodegeneration, Alzheimer's disease.

Published: April 8, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matušková V, Vyhnálek M. Mild behavioral impairment as a prodromal stage of neurodegenerative diseases. Psychiatr. praxi. 2022;23(1):13-16. doi: 10.36290/psy.2022.002.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gallagher D, Fischer CE, Iaboni A. Neuropsychiatric Symptoms in Mild Cognitive Impairment. Can J Psychiatry. 2017;62(3):161-9. Go to original source... Go to PubMed...
    2. Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos J­‑M. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers. Alzheimers Dement (Amst). 2019;11:333-9. Go to original source... Go to PubMed...
    3. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):126-33. Go to original source... Go to PubMed...
    4. Cummings J. The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases. Am J Geriatr Psychiatry. 2021;29(4):375-83. Go to original source... Go to PubMed...
    5. Eikelboom WS, Berg E van den, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, et al. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross­‑sectional and Longitudinal Associations. Neurology. 2021;97(13):e1276-87. Go to original source... Go to PubMed...
    6. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743-55. Go to original source... Go to PubMed...
    7. Benussi A, Alberici A, Samra K, Russell LL, Greaves CV, Bocchetta M, et al. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimers Dement. 2021 Go to original source...
    8. Rusina R, Matej R, Cséfalvay Z, Keller J, Franková V, Vyhnálek M. Frontotemporální demence. Cesk Slov Neurol N. 2021;84(117):9-29. Go to original source...
    9. Tiel C, Sudo FK, Alves GS, Ericeira­‑Valente L, Moreira DM, Laks J, et al. Neuropsychiatric symptoms in Vascular Cognitive Impairment: a systematic review. Dement Neuropsychol. 2015;9(3):230-6. Go to original source... Go to PubMed...
    10. Roberto N, Portella MJ, Marquié M, Alegret M, Hernández I, Mauleón A, et al. Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Sci Rep. 2021;11(1):6448. Go to original source... Go to PubMed...
    11. Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195-202. Go to original source... Go to PubMed...
    12. Matuskova V, Nikolai T, Markova H, Cechova K, Laczo J, Hort J, et al. Neuropsychiatrické symptomy jako časná manifestace Alzheimerovy nemoci. Cesk Slov Neurol N. 2020;83(1):64-72. Go to original source...
    13. Gitlin LN, Marx KA, Stanley IH, Hansen BR, Van Haitsma KS. Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures. Int Psychogeriatr. 2014;26(11):1805-48. Go to original source... Go to PubMed...
    14. Ismail Z, Agüera­‑Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The Mild Behavioral Impairment Checklist (MBI­‑C): A Rating Scale for Neuropsychiatric Symptoms in Pre­‑Dementia Populations. J Alzheimers, DiS. 2017;56(3):929-38. Go to original source... Go to PubMed...
    15. Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo­‑Seoane C, Campos­‑Magdaleno M, et al. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment­‑Checklist in People with Mild Cognitive Impairment. J Alzheimers, DiS. 2018;66(1):83-95. Go to original source... Go to PubMed...
    16. Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo­‑Seoane C, Campos­‑Magdaleno M, et al. Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline. Int Psychogeriatr. 2018;1-9. Go to original source... Go to PubMed...
    17. Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova K, Nedelska Z, et al. Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort. Front Aging Neurosci. 2021;13:643271. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.